Month: September 2021

In the last 6 years, almost 55,000 cancer patients should have been diagnosed quicker or started their treatment sooner, according to new calculations from Cancer Research UK released today. This is because, in England, the NHS has continued to miss its target to treat 85% of cancer patients within 2 months of their urgent suspected
0 Comments
Learn to manage conflict sensitively and calmly, with these handy phrases When emotions are running high, the way that we phrase our thoughts and feelings can help keep difficult conversations productive and kind. Next time you’re trying to navigate conflict, use these phrases to help you keep the peace, without neglecting your needs and boundaries
0 Comments
The US Food and Drug Administration (FDA) has approved ruxolitinib (Jakafi) for treatment of chronic graft-versus-host disease (GVHD) in adults and in pediatric patients 12 years and older who have already had one or two lines of systemic therapy. The product, a JAK inhibitor first marketed for use in myelofibrosis, is already approved for acute GVHD
0 Comments
Scientists from the USA have recently compared the dynamics of humoral and cellular immune responses induced by mRNA-based and adenoviral vector-based coronavirus disease 2019 (COVID-19) vaccines. The findings reveal a difference in humoral immune responses. The study is currently available on the medRxiv* preprint server. Background In the USA, three COVID-19 vaccines have been approved
0 Comments
Businessman walk past an Emirates Airbus A380 during the Dubai Airshow on November 18, 2013 in Dubai, United Arab Emirates. Christopher Furlong | Getty Images The U.K. will accept travelers vaccinated in the United Arab Emirates beginning Oct. 4, Transport Secretary Grant Shapps said Wednesday, reopening a popular travel route after months of deterring people
0 Comments
LDL cholesterol (LDL-C) exposure in younger adulthood predicted later cardiovascular events independent of cholesterol in middle age, large observational cohorts showed. Coronary heart disease significantly correlated with cumulative LDL-C (HR 1.57, P=0.01 for trend) as well as time-weighted average LDL (HR 1.69, P<0.001 for trend) across four studies and a median of 16 years of
0 Comments
A common antibiotic has been found to reduce low birth weight and premature births, if taken during pregnancy, in countries where malaria is endemic, according to a research review. The systematic review, led by the Murdoch Children’s Research Institute (MCRI) and published in The Lancet EClinicalMedicine, found that the antibiotic, azithromycin, reduced low birth weight
0 Comments
Triple-negative breast cancer is notoriously hard to treat and tends to be more aggressive. It’s also more common among Black women. A new study has found just how much higher the risk is for this group. Researchers from the University of Pennsylvania looked at the mammogram histories of just under 200,000 patients, including about 30,000
0 Comments
Get your creative juices flowing with these seasonal activities Crafting is an incredible activity for wellbeing. It not only helps kids develop fine motor and problem-solving skills, but gives their self-esteem, creativity, and confidence a boost, too. And what just might be the best and most brilliant of all craft resources? Nature: it’s free, readily
0 Comments
While more and more cases of COVID-19 in children are being reported recently, the FDA is in the final process of authorizing the administration of the biological preparation in the younger population, with experts saying the federal agency could release its verdict in the coming weeks.  Spike In Cases Among Children The American Academy of
0 Comments
From testing to treatment, Global Fund HIV services have been hampered by COVID-19. “We’ve been set back by COVID but we’ve seen remarkable resilience, a lot of innovation and creativity,” Siobhan Crowley MD, Head of HIV at the Global Fund, told Medscape Medical News.  Dr Siobhan Crowley “If you consider that 21.9M people are getting
0 Comments
Peer review is an incredibly important part of how we maintain the excellence of the research we fund. As part of Peer Review Week, we are very proud to celebrate the essential role our research community play in this process. Here we chat to Professor Marcus Munafò – a member of one of our funding committees
0 Comments
Not having health insurance is riskier and more costly than investing in one. You may be healthy and free from medical conditions now, but what about when an unexpected situation strikes? As not everyone can easily afford health insurance, at least you now have the option to apply for a short-term health insurance plan instead. What is Short-Term
0 Comments
The US Food and Drug Administration (FDA) has granted accelerated approval to tisotumab vedotin-tftv (Tivdak, Seagen/Genmab) for the treatment of adult patients with recurrent or metastatic cervical cancer who have experienced disease progression on or after chemotherapy. There is currently no standard option for these patients. The mainstay of therapy in this setting is monotherapy
0 Comments
Coronavirus disease 2019 (COVID-19) disproportionately affects patients 65 years and older. Age-related impaired host immunity has been implicated for severe outcomes of COVID-19. Researchers have performed a study on large data set to understand better the molecular basis of vulnerability in aged COVID-19 patients. They observed certain age-linked immunoinflammatory factors associated with severe COVID-19 and
0 Comments
The FDA granted accelerated approval to tisotumab vedotin-tftv (Tivdak), a first-in-class drug, for the treatment of patients with recurrent or metastatic cervical cancer, drugmakers Seagen and Genmab announced. Tisotumab vedotin, a tissue factor-directed antibody and microtubule inhibitor conjugate, is indicated for women whose disease progressed on or following chemotherapy. Approval was based on findings from
0 Comments
A parent-led therapy that supports the social development of babies displaying early signs of autism has significantly reduced the likelihood of an autism diagnosis being made in early childhood, according to world-first research led by CliniKids atthe Telethon Kids Institute. In a study published in JAMA Pediatrics, an international research team led by Professor Andrew
0 Comments
Breast cancer cells. Researchers have presented ‘striking’ data showing the power of a targeted drug to slow breast cancer growth. This data is nothing short of phenomenal and will be practice changing. – Dr Sara Hurvitz, study author The breakthrough drug works by delivering high concentrations of chemotherapy directly to cancer cells that have a
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. COVID-19 has now killed at least 675,000 Americans, a death toll that has surpassed the estimates of the number of Americans who died during the 1918 influenza pandemic, according to data collected by Johns Hopkins University. Although the raw numbers match,
0 Comments
The delta variant of the novel coronavirus has brought forth massive spikes in COVID-19 transmissions in the country and across the globe. And though children are also seeing a surge in cases, there is no cause for alarm among the younger population.  COVID-19 In Kids In the U.S., transmissions involving children under 12 have soared
0 Comments
The US Food and Drug Administration (FDA) has approved the first biosimilar for ophthalmology, Byooviz (ranibizumab-nuna), which will be indicated for neovascular (wet) age-related macular degeneration (nAMD), macular edema following retinal vein occlusion, and myopic choroidal neovascularization, a vision-threatening complication of myopia. The reference product for Byooviz (Samsung Bioepis/Biogen) is Lucentis (ranibizumab injection, Roche), which
0 Comments